Dnca Finance Has $10.48 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Dnca Finance trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 6.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 78,000 shares of the medical research company's stock after selling 5,000 shares during the period. Dnca Finance's holdings in Agilent Technologies were worth $10,479,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Flynn Zito Capital Management LLC raised its position in Agilent Technologies by 3.8% in the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock worth $251,000 after acquiring an additional 69 shares in the last quarter. IFP Advisors Inc raised its holdings in shares of Agilent Technologies by 17.7% in the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock worth $62,000 after purchasing an additional 69 shares in the last quarter. Tiemann Investment Advisors LLC boosted its holdings in Agilent Technologies by 5.6% during the fourth quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company's stock worth $191,000 after buying an additional 75 shares in the last quarter. Rothschild Investment LLC grew its position in Agilent Technologies by 19.2% in the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock worth $66,000 after buying an additional 79 shares during the last quarter. Finally, CIBC Private Wealth Group LLC lifted its position in shares of Agilent Technologies by 1.2% during the 4th quarter. CIBC Private Wealth Group LLC now owns 7,479 shares of the medical research company's stock valued at $1,025,000 after acquiring an additional 87 shares during the last quarter.

Agilent Technologies Stock Performance

Shares of NYSE A traded up $0.93 during trading hours on Thursday, hitting $105.93. 675,328 shares of the stock were exchanged, compared to its average volume of 1,863,366. The firm has a market capitalization of $30.20 billion, a P/E ratio of 24.35, a P/E/G ratio of 2.90 and a beta of 1.19. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $155.35. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. The company's 50 day moving average is $117.53 and its 200 day moving average is $131.61.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. On average, research analysts expect that Agilent Technologies, Inc. will post 5.54 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were paid a dividend of $0.248 per share. The ex-dividend date of this dividend was Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.94%. Agilent Technologies's dividend payout ratio is 22.76%.

Analyst Ratings Changes

A has been the subject of several analyst reports. Robert W. Baird reduced their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a report on Thursday, February 27th. Jefferies Financial Group dropped their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday. Barclays decreased their price objective on shares of Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Wells Fargo & Company cut their target price on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Finally, TD Cowen lifted their price target on Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Thursday, April 10th. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus price target of $143.00.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now directly owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.